inspiremd inc k apr    pm  seeking alphasign in  join nowgo»inspiremd inc nsprform k  current reportapr    pmabout inspiremd inc nsprview as pdf inspiremd inc form k received         united states securities and exchange commission washington dc        form k   current report   pursuant to section  or d of the securities exchange act of        date of report date of earliest event reported april     inspiremd inc exact name of registrant as specified in its charter   delaware       state or other jurisdiction of incorporation   commission file number   irs employer identification no    menorat hamaor st tel aviv israel    address of principal executive offices   zip code   registrant’s telephone number including area code       former name or former address if changed since last report       check the appropriate box below if the form k filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions      written communications pursuant to rule  under the securities act  cfr         soliciting material pursuant to rule a under the exchange act  cfr a        precommencement communications pursuant to rule db under the exchange act  cfr db        precommencement communications pursuant to rule e c under the exchange act  cfr ec             item  other events   on april   inspiremd inc the “company” announced the listing of series b warrants on the nyse mkt beginning at the market open on april   a copy of the press release is attached as exhibit  to this current report on form k and is hereby incorporated by reference herein   on april   the company announced entering into a distribution agreement with angiocare bv for distribution of cguard tm eps in the netherlands a copy of the press release is attached as exhibit  to this current report on form k and is hereby incorporated by reference herein   item  financial statements and exhibits   d exhibits   exhibit number   description    press release dated april      press release dated april           signatures   pursuant to the requirements of the securities exchange act of  as amended the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized   inspiremd inc   date april   by s craig shore   name craig shore   title chief financial officer         click to enlarge   inspiremd announces listing of series b warrants on the nyse mkt   tel aviv—april    inspiremd inc nyse mktnspr nyse mktnsprws “inspiremd” or the “company” a leader in embolic prevention systems eps  thrombus management technologies and neurovascular devices today announced the listing of the company’s  previously issued series b warrants on the nyse mkt the “exchange” beginning at the market open april   the series b warrants will commence trading under the ticker symbol “nsprwsb” these series b warrants are in addition to the series a warrants already listed on the nyse mkt trading under the ticker symbol “nsprws”   on march   inspiremd announced the closing of a public offering of approximately  million which included the issuance of these  series b warrants each series b warrant entitles the holder to purchase one share of common stock of inspiremd at an exercise price of  and expires on march     about inspiremd inc   inspiremd seeks to utilize its proprietary micronet™ technology to make its products the industry standard for embolic protection and to provide a superior solution to the key clinical issues of current stenting in patients with a high risk of distal embolization no reflow and major adverse cardiac events   inspiremd intends to pursue applications of this micronet technology in coronary carotid cguard™ neurovascular and peripheral artery procedures inspiremd’s common stock is quoted on the nyse mkt under the ticker symbol nspr and certain warrants are quoted on the nyse mkt under the ticker symbol nsprws         forwardlooking statements   this press release contains “forwardlooking statements” such statements may be preceded by the words “intends” “may” “will” “plans” “expects” “anticipates” “projects” “predicts” “estimates” “aims” “believes” “hopes” “potential” or similar words forwardlooking statements are not guarantees of future performance are based on certain assumptions and are subject to various known and unknown risks and uncertainties many of which are beyond the company’s control and cannot be predicted or quantified and consequently actual results may differ materially from those expressed or implied by such forwardlooking statements such risks and uncertainties include without limitation risks and uncertainties associated with i market acceptance of our existing and new products ii negative clinical trial results or lengthy product delays in key markets iii an inability to secure regulatory approvals for the sale of our products iv intense competition in the medical device industry from much larger multinational companies v product liability claims vi product malfunctions vii our limited manufacturing capabilities and reliance on subcontractors for assistance viii insufficient or inadequate reimbursement by governmental and other third party payers for our products ix our efforts to successfully obtain and maintain intellectual property protection covering our products which may not be successful x legislative or regulatory reform of the healthcare system in both the us and foreign jurisdictions xi our reliance on single suppliers for certain product components xii the fact that we will need to raise additional capital to meet our business requirements in the future and that such capital raising may be costly dilutive or difficult to obtain and xiii the fact that we conduct business in multiple foreign jurisdictions exposing us to foreign currency exchange rate fluctuations logistical and communications challenges burdens and costs of compliance with foreign laws and political and economic instability in each jurisdiction more detailed information about the company and the risk factors that may affect the realization of forward looking statements is set forth in the company’s filings with the securities and exchange commission sec including the company’s annual report on form k and its quarterly reports on form q investors and security holders are urged to read these documents free of charge on the sec’s web site at httpwwwsecgov the company assumes no obligation to publicly update or revise its forwardlooking statements as a result of new information future events or otherwise   investor contacts   inspiremd inc craig shore chief financial officer phone  free email craigsinspiremdcom   crescendo communications llc david waldman phone   email nsprcrescendoircom         click to enlarge   inspiremd announces distribution agreement for cguard tm eps in the netherlands   tel aviv—april    inspiremd inc nyse mktnspr nyse mktnsprws “inspiremd” or the “company” a leader in embolic prevention systems eps  thrombus management technologies and neurovascular devices today announced it has signed an agreement with angiocare bv a leading medical distributor in the netherlands to distribute cguard tm eps embolic prevention system   agustin gago evp and chief commercial officer of inspiremd commented “our new partner in the netherlands marks another important step towards building a local distribution model for inspiremd’s cguard eps across europe”   mr john visscher ceo of angiocare bv stated “we are delighted to offer cguard through our extensive physician network across the netherlands we believe that cguard will rapidly become the standardofcare due to its potential safety advantages for patients with carotid artery disease”   about inspiremd inc   inspiremd seeks to utilize its proprietary micronet™ technology to make its products the industry standard for embolic protection and to provide a superior solution to the key clinical issues of current stenting in patients with a high risk of distal embolization no reflow and major adverse cardiac events   inspiremd intends to pursue applications of this micronet technology in coronary carotid cguard™ neurovascular and peripheral artery procedures inspiremd’s common stock is quoted on the nyse mkt under the ticker symbol nspr and certain warrants are quoted on the nyse mkt under the ticker symbol nsprws         forwardlooking statements   this press release contains “forwardlooking statements” such statements may be preceded by the words “intends” “may” “will” “plans” “expects” “anticipates” “projects” “predicts” “estimates” “aims” “believes” “hopes” “potential” or similar words forwardlooking statements are not guarantees of future performance are based on certain assumptions and are subject to various known and unknown risks and uncertainties many of which are beyond the company’s control and cannot be predicted or quantified and consequently actual results may differ materially from those expressed or implied by such forwardlooking statements such risks and uncertainties include without limitation risks and uncertainties associated with i market acceptance of our existing and new products ii negative clinical trial results or lengthy product delays in key markets iii an inability to secure regulatory approvals for the sale of our products iv intense competition in the medical device industry from much larger multinational companies v product liability claims vi product malfunctions vii our limited manufacturing capabilities and reliance on subcontractors for assistance viii insufficient or inadequate reimbursement by governmental and other third party payers for our products ix our efforts to successfully obtain and maintain intellectual property protection covering our products which may not be successful x legislative or regulatory reform of the healthcare system in both the us and foreign jurisdictions xi our reliance on single suppliers for certain product components xii the fact that we will need to raise additional capital to meet our business requirements in the future and that such capital raising may be costly dilutive or difficult to obtain and xiii the fact that we conduct business in multiple foreign jurisdictions exposing us to foreign currency exchange rate fluctuations logistical and communications challenges burdens and costs of compliance with foreign laws and political and economic instability in each jurisdiction more detailed information about the company and the risk factors that may affect the realization of forward looking statements is set forth in the company’s filings with the securities and exchange commission sec including the company’s annual report on form k and its quarterly reports on form q investors and security holders are urged to read these documents free of charge on the sec’s web site at httpwwwsecgov the company assumes no obligation to publicly update or revise its forwardlooking statements as a result of new information future events or otherwise   investor contacts   inspiremd inc craig shore chief financial officer phone  free email craigsinspiremdcom   crescendo communications llc david waldman phone   email nsprcrescendoircom       stocks index  markets index bulletin investor alert stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest abreakingelon musk details tesla model  pricing range atesla standard model  will cost  longrange model will cost  pwall street isn’t ready for a point tumble in the dow industrials pbarrons buzz robo  facebook and twitter trading on news pa wild week in washington pthe dark side of cruises pthe highest paid athletes in the world in one chart poj simpson made over  while in prison and won’t have to give any of it to the goldman family p trump to police dont be too nice phere are  coworkers you should avoid like the plague — especially in meetings ptop  most annoying people you may want to unfriend on facebook pthis is one person you should never unfriend on facebook p horrible ways typos could alter the course of your life ppaint your bathroom this color and boost your home’s selling price by  pamericans’ new badge of honor ‘i was blocked by a celebrity’ p weird things i found out about america in my first  hours pbeyond tesla  stocks driving the autonomous car revolution pthese  highly taxed companies need congress to finally act on tax reform pwatch out ‘kids’ are making the most money in this stock market p real ways for millennials to save money not by brownbagging and skipping starbucks loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  stockscountryunited states index  markets index bulletin investor alert stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies location united states name exchange sector  communique laboratory inc ocqlf ootc software  property insurance holdings inc pih xnas nonlife insurance flowerscom inc cl a flws xnas specialty retail pm industries inc opmz ootc food products st capital bank ca fisb ootc banking st constitution bancorp fccy xnas banking st nrg corp fnrc ootc oil extraction st source corp srce xnas banking  motors inc etfm ootc automobiles st century fox inc cl a foxa xnas broadcasting st century fox inc cl b fox xnas broadcasting vianet group inc adr vnet xnas internetonline nd century group inc xxii xase biotechnology  kid doc inc tvmd ootc healthcare provision u inc twou xnas software xleveraged long etracs linked to wells fargo business development co index  bdcl arcx major international banks xleveraged long etracs wells fargo business development lbdc arcx major international banks d eye solutions inc tdey ootc motion picturesound recording d pioneer systems inc dpsm ootc software d systems corp ddd xnys computersconsumer electronics dicon corp tdcp ootc software dshoppingcom thds ootc mixed retailing dx industries inc dddx ootc computersconsumer electronics i group plc adr tgopy ootc finance companies m co mmm xnys diversified holding companies pea international inc tpnl xotc accounting power energy group inc pspw ootc renewable energy generation tl technologies corp ttmzf ootc advertisingmarketingpublic relations  property management inc ftpm ootc real estate agentsbrokers cable tv international inc catv ootc diversified business services licensing corp fourq ootc diversified business services com ltd adr wbai xnys gambling industries job inc adr jobs xnas employmenttraining services com inc adr wuba xnys consumer services barz international inc barz ootc networking n plus inc fplsf ootc commodity chemicals d global technologies inc sixd ootc computer services  renewable energy corp rnwr ootc multiutilities  energy ltd adr tngry ootc oil extraction  holdings plc eihdf ootc gambling industries point energy partners lp cafd xnas renewable energy generation x inc eght xnas wired telecommunications services a clean slate inc drwn ootc diversified business services aw revenue royalties income fund awrrf ootc restaurants a h belo corp series a ahc xnys publishing a schulman inc shlm xnas commodity chemicals a schulman inc  pfd slmnp ootc commodity chemicals ad makepeace co make ootc farming am castle  co cas xnys wholesalers ao smith corp aos xnys building materialsproducts ap moellermaersk as adr amkby ootc water transportshipping ap moellermaersk as series a amkaf ootc water transportshipping ap moellermaersk as series b amkbf ootc water transportshipping as roma spa asraf ootc recreational services a group inc awon ootc tobacco a networks inc aten xnys computer services a milk co ltd acopf ootc biotechnology aac holdings inc aac xnys healthcare provision aac technologies holdings inc aacaf ootc industrial electronics aac technologies holdings inc adr aacay ootc industrial electronics aaon inc aaon xnas building materialsproducts aap inc aapj ootc food products aar corp air xnys aerospace productsparts aarons inc aan xnys consumer services ab science sa abscf ootc pharmaceuticals ab svensk exportkredit elements linked to mlcx biofuels index total return fue arcx finance companies ab svensk exportkredit elements linked to mlcx grain index total return gru arcx finance companies abt financial corp abto ootc banking abacus mining  exploration corp abcff ootc general mining abakan inc abki ootc industrial products abattis bioceuticals corp attbf ootc biotechnology abaxis inc abax xnas medical equipmentsupplies abb ltd ablzf ootc industrial machinery abb ltd adr abb xnys industrial machinery abbott laboratories abt xnys pharmaceuticals abbvie inc abbv xnys biotechnology abby inc abby ootc oil extraction abcam plc abczf ootc biotechnology abcam plc adr abczy ootc biotechnology abco energy inc abce ootc industrial machinery abcourt mines inc abmbf ootc general mining aben resources ltd abnaf ootc general mining abengoa sa b agoaf ootc construction abeona therapeutics inc abeo xnas biotechnology abeona therapeutics inc wt abeow xnas abercrombie  fitch co anf xnys clothing retail aberdeen asiapacific income fund inc fax xase closedend funds aberdeen asiapacific income investment co ltd abakf ootc closedend funds aberdeen asset management plc abdnf ootc investment advisors aberdeen asset management plc adr abdny ootc investment advisors aberdeen australia equity fund inc iaf xase closedend funds aberdeen chile fund inc ch xase closedend funds aberdeen emerging markets smaller company opportunities fund inc abe xase closedend funds aberdeen global income fund inc fco xase closedend funds aberdeen greater china fund inc gch xnys closedend funds aberdeen indonesia fund inc if xase closedend funds aberdeen international inc aabvf ootc general mining aberdeen israel fund inc isl xase closedend funds aberdeen japan equity fund inc jeq xnys closedend funds aberdeen latin america equity fund inc laq xase closedend funds aberdeen singapore fund inc sgf xnys closedend funds abertis infraestructuras sa adr abrty ootc transportation services ability inc abil xnas precision products ability inc wt abiwf ootc abiomed inc abmd xnas medical equipmentsupplies abitibi royalties inc atbyf ootc general mining able energy inc able ootc gas utilities ablynx nv ablyf ootc biotechnology abm industries inc abm xnys diversified business services abraxas petroleum corp axas xnas oil extraction absecon bancorp ascn ootc banking absolute health  fitness inc ahfi ootc recreational services absolute software corp alswf ootc software abt holdings inc abot ootc precious metals abtech holdings inc abhd ootc industrial machinery abv consulting inc abvn ootc advertisingmarketingpublic relations ac immune sa aciu xnas biotechnology acacia communications inc acia xnas networking acacia diversified holdings inc acca ootc specialty retail acacia mining plc abglf ootc gold acacia research corp  acacia technologies actg xnas diversified business services acadia healthcare co inc achc xnas healthcare provision acadia pharmaceuticals inc acad xnas biotechnology acadia realty trust akr xnys acadian timber corp acazf ootc forestry  wood products acasti pharma inc acst xnas pharmaceuticals accelera innovations inc acnv ootc healthcare provision accelerate diagnostics inc axdx xnas biotechnology accelerize inc aclz xotc life insurance acceleron pharma inc xlrn xnas biotechnology accenture plc cl a acn xnys diversified business services access national corp ancx xnas banking access power inc accr ootc wired telecommunications services access worldwide communications inc awwc ootc advertisingmarketingpublic relations acciona sa acxif ootc construction acco brands corp acco xnys nondurable household products accor sa acrff ootc hotels accor sa adr accyy ootc hotels accordia golf co ltd acgff ootc recreational services accredited mortgage loan reit trust  perp cum pfd series a ahhap ootc mortgages accretive health inc achi ootc healthcare provision accuray inc aray xnas medical equipmentsupplies accuride corp acw xnys auto  commercial vehicle parts acelrx pharmaceuticals inc acrx xnas pharmaceuticals acer inc gdr reg s aceyy ootc computersconsumer electronics acerus pharmaceuticals corp trlpf ootc biotechnology aceto corp acet xnas specialty chemicals achaogen inc akao xnas biotechnology achillion pharmaceuticals inc achn xnas biotechnology aci worldwide inc aciw xnas software «» log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest abreakingelon musk details tesla model  pricing range atesla standard model  will cost  longrange model will cost  pwall street isn’t ready for a point tumble in the dow industrials pbarrons buzz robo  facebook and twitter trading on news pa wild week in washington pthe dark side of cruises pthe highest paid athletes in the world in one chart poj simpson made over  while in prison and won’t have to give any of it to the goldman family p trump to police dont be too nice phere are  coworkers you should avoid like the plague — especially in meetings ptop  most annoying people you may want to unfriend on facebook pthis is one person you should never unfriend on facebook p horrible ways typos could alter the course of your life ppaint your bathroom this color and boost your home’s selling price by  pamericans’ new badge of honor ‘i was blocked by a celebrity’ p weird things i found out about america in my first  hours pbeyond tesla  stocks driving the autonomous car revolution pthese  highly taxed companies need congress to finally act on tax reform pwatch out ‘kids’ are making the most money in this stock market p real ways for millennials to save money not by brownbagging and skipping starbucks loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  stocks index  markets index bulletin investor alert stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest abreakingelon musk details tesla model  pricing range atesla standard model  will cost  longrange model will cost  pwall street isn’t ready for a point tumble in the dow industrials pbarrons buzz robo  facebook and twitter trading on news pa wild week in washington pthe dark side of cruises pthe highest paid athletes in the world in one chart poj simpson made over  while in prison and won’t have to give any of it to the goldman family p trump to police dont be too nice phere are  coworkers you should avoid like the plague — especially in meetings ptop  most annoying people you may want to unfriend on facebook pthis is one person you should never unfriend on facebook p horrible ways typos could alter the course of your life ppaint your bathroom this color and boost your home’s selling price by  pamericans’ new badge of honor ‘i was blocked by a celebrity’ p weird things i found out about america in my first  hours pbeyond tesla  stocks driving the autonomous car revolution pthese  highly taxed companies need congress to finally act on tax reform pwatch out ‘kids’ are making the most money in this stock market p real ways for millennials to save money not by brownbagging and skipping starbucks loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  inspiremd nspr key statistics  inspiremd inc financial ratios  marketwatch bulletin investor alert expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close inspiremd inc nyse american nspr go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus inspiremd inc market closed  quotes are delayed by  min jul    pm nspr quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite previous close     change   day low day high    week low  week high   company description inspiremd inc is a medical device company which engages in the development and commercialization of the stent platform technology for the treatment of complex vascular and coronary disease its products are marketed for use mainly in patients with acute coronary syndromes notably acute myocardia inspiremd inc is a medical device company which engages in the development and commercialization of the stent platform technology for the treatment of complex vascular and coronary disease its products are marketed for use mainly in patients with acute coronary syndromes notably acute myocardial infarction and saphenous vein graft coronary interventions the company was founded in  and is headquartered in tel aviv israel valuation pe current  pe ratio with extraordinary items  price to sales ratio  price to book ratio  enterprise value to ebitda  enterprise value to sales  total debt to enterprise value  efficiency revenueemployee  income per employee  receivables turnover  total asset turnover  liquidity current ratio  quick ratio  cash ratio  profitability gross margin  operating margin  pretax margin  net margin  return on assets  return on equity  return on total capital  return on invested capital  capital structure total debt to total equity  total debt to total capital  total debt to total assets  officers and executives name age officer since title dr james j barry   president chief executive officer  director mr benzi spector   headoperations research  development mr craig shore   chief financial officer secretary  treasurer mr agustin v gago   chief commercial officer  executive vp mr paul s stuka   chairman insider actions – purchase – sale  – number of transactions  date name shares transaction value  james j barry president and ceo director    derivativenonderivative trans at  per share   james j barry president and ceo director    award at  per share   craig shore cfo and cao    award at  per share   james j barry president and ceo director    derivativenonderivative trans at  per share   sol j barer director    acquisition at  per share   osiris investment partners llc director    acquisition at  per share   campbell rogers director    acquisition at  per share   james j loughlin director    acquisition at  per share   alan w milinazzo president and ceo director    derivativenonderivative trans at  per share   alan w milinazzo president and ceo director    derivativenonderivative trans at  per share   james j barry president and ceo director    derivativenonderivative trans at  per share   alan w milinazzo president and ceo director    derivativenonderivative trans at  per share   james j barry president and ceo director    award at  per share   sol j barer director    award at  per share   campbell rogers director    award at  per share   michael l berman director    award at  per share   alan w milinazzo president and ceo director    award at  per share   craig shore cfo and cao    award at  per share   james j loughlin director    award at  per share   paul s stuka director    award at  per share   alan w milinazzo president and ceo director    derivativenonderivative trans at  per share   alan w milinazzo president and ceo director    derivativenonderivative trans at  per share   alan w milinazzo president and ceo director    award at  per share  newslatestcompanyusnspr marketwatch news on nspr us steel surges on strategic moves adobe slides after revenue miss  pm sept    wallace witkowski newsnonmarketwatchcompanyusnspr other news on nspr inspiremds nspr ceo jim barry on q  results  earnings call transcript  pm may    seeking alpha q inspiremd inc  pm may    edgar online  edg  q k inspiremd nspr investor presentation  slideshow  pm march    seeking alpha inspiremd almost gets there with best efforts equity offering raises m shares slip   pm march    seeking alpha inspiremd down  on equity offering  pm march    seeking alpha longterm followup data show success of inspiremds cguard eps shares up   pm nov    seeking alpha q inspiremd inc  pm aug    edgar online  edg  q k inspiremd prices equity offering shares down   pm july    seeking alpha  growth stocks to buy near their week lows  am april    zackscom inspiremd reports q and fy results  am march    seeking alpha insiders roundup sales on facebook  pm march    gurufocuscom insiderinsightscom daily round up  codi ovas nspr flks  am march    seeking alpha new chief on the way at inspiremd  am jan    seeking alpha the impact of a reverse stock split  am dec    seeking alpha inspiremds nspr ceo alan milinazzo on q  results  earnings call transcript  pm nov    seeking alpha inspiremds nspr ceo alan milinazzo on q  results  earnings call transcript  pm aug    seeking alpha inspiremds nspr ceo alan milinazzo on q  results  earnings call transcript  pm may    seeking alpha inspiremds nspr ceo alan milinazzo on q  results  earnings call transcript  pm march    seeking alpha inspiremd plunges on equity offer dilution  pm march    seeking alpha inspiremd inc nspr surges stock moves  higher  tale of the tape  am oct    zackscom loading more headlines at a glance inspiremd inc  menorat hamaor street tel aviv ta  phone   industry medical equipmentsupplies sector health carelife sciences fiscal yearend  view sec filings revenue m net income m employees  annual report for nspr newspressreleasecompanyusnspr press releases on nspr todays research report coverage on medical equipment stocks  novocure corindus vascular robotics inspiremd and nxstage medical  am july    pr newswire  prf inspiremd announces completion of transition from exclusive european distributor to inspiremd managed local distribution network  am june    marketwired inspiremd to present at the  marcum microcap conference  am june    marketwired inspiremd announces distribution agreement for cguard eps in taiwan  am june    marketwired inspiremd announces the publication of an investigator initiated clinical registry reaffirming mguardtm prime as a highly effective tool to prevent heart damage in coronary artery blockages with high thrombotic content  am june    marketwired inspiremd announces distribution agreement for cguardtm eps in poland  am june    marketwired inspiremd announces appointment of paul stuka as chairman of the board  am june    marketwired inspiremd to present at the th annual seethruequity microcap investor conference  am may    accesswire inspiremd announces first two patients in hong kong successfully treated with cguard eps  am may    marketwired research reports initiation on medical equipment stocks  corindus vascular robotics inspiremd xtant medical and second sight medical products  am may    pr newswire  prf inspiremds cguardtm carotid embolic prevention system featured in live case transmission at europcr   am may    accesswire inspiremd announces publication of the ironguard registry in eurointervention  am may    accesswire inspiremd announces distribution agreements for cguardtm eps and mguard primetm eps in peru and ecuador  am may    accesswire inspiremd provides business update for the first quarter of   pm may    accesswire inspiremd schedules first quarter  earnings conference call  pm may    accesswire inspiremd announces distribution agreement for cguardtm eps in germany  am may    accesswire inspiremd announces distribution agreement for cguardtm eps in the netherlands  am april    accesswire inspiremd announces listing of series b warrants on the nyse mkt  pm april    accesswire inspiremd announces distribution agreement for cguardtm in turkey  am april    accesswire inspiremd announces commercial launch of cguardtm eps in the russian federation at the icca stroke event in moscow  am march    accesswire loading more headlines trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest abreakingelon musk details tesla model  pricing range atesla standard model  will cost  longrange model will cost  pwall street isn’t ready for a point tumble in the dow industrials pbarrons buzz robo  facebook and twitter trading on news pa wild week in washington pthe dark side of cruises pthe highest paid athletes in the world in one chart poj simpson made over  while in prison and won’t have to give any of it to the goldman family p trump to police dont be too nice phere are  coworkers you should avoid like the plague — especially in meetings ptop  most annoying people you may want to unfriend on facebook pthis is one person you should never unfriend on facebook p horrible ways typos could alter the course of your life ppaint your bathroom this color and boost your home’s selling price by  pamericans’ new badge of honor ‘i was blocked by a celebrity’ p weird things i found out about america in my first  hours pbeyond tesla  stocks driving the autonomous car revolution pthese  highly taxed companies need congress to finally act on tax reform pwatch out ‘kids’ are making the most money in this stock market p real ways for millennials to save money not by brownbagging and skipping starbucks loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  nspr profile  inspiremd inc stock  yahoo financehomemailflickrtumblrnewssportsfinancecelebrityanswersgroupsmobilemoreyahoosearchsearchus markets closedsp  dow  listenwho is the face of pro baseballyahoo finances dan roberts and myles udland debate the business of baseballinspiremd inc nsprnyse mkt  nyse mkt delayed price currency in usdadd to watchlist at close pm edtpeople also watchsklnamdaidxgnvcnopgnsummaryconversationsstatisticsprofilefinancialsoptionsholdershistorical dataanalystsinspiremd inc menorat hamaor streettel aviv israel  httpwwwinspiremdcomsector healthcareindustry medical appliances  equipmentfull time employees key executivesnametitlepayexercisedagedr james j barry phdchief exec officer pres and directorknamr craig shorechief financial officer chief admin officer treasurer and secknamr agustin v gagochief commercial officer and exec vpknadr sol j barer phdspecial advisor to the boardknamr benzi spectorhead of rd and operationsnananaamounts are as of december   and compensation values are for the last fiscal year ending on that date pay is salary bonuses etc exercised is the value of options exercised during the fiscal year currency in usddescriptioninspiremd inc a medical device company focuses on the development and commercialization of proprietary micronet stent platform technology for the treatment of complex coronary and vascular diseases it offers mguard prime embolic protection systems for use in patients with acute coronary syndromes notably acute myocardial infarction and saphenous vein graft coronary interventions and cguard carotid embolic prevention systems for use in carotid artery applications the company is also developing nvguard a neurovascular flow diverter that diverts blood flow away from cerebral aneurysms and seals the aneurysms inspiremd inc distributes its products in europe latin america the middle east and asia the company is headquartered in tel aviv israelcorporate governanceinspiremd inc’s iss governance qualityscore as of na is na the pillar scores are audit na board na shareholder rights na compensation nacorporate governance scores courtesy of institutional shareholder services iss scores indicate decile rank relative to index or region a decile score of  indicates lower governance risk while a  indicates higher governance riskyahoo small businessdata disclaimerhelpsuggestionsprivacyabout our adsterms updated nspr stock price  inspiremd inc stock quote us nyse american  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers algn  mhk  col  lyb  fls  mo  sbux  gt  latest newsall times eastern a breaking elon musk details tesla model  pricing range a tesla standard model  will cost  longrange model will cost   updated wall street isn’t ready for a point tumble in the dow industrials  barrons buzz robo  facebook and twitter trading on news  a wild week in washington  updated the dark side of cruises  trump to police dont be too nice  updated the highest paid athletes in the world in one chart  updated oj simpson made over  while in prison and won’t have to give any of it to the goldman family  updated here are  coworkers you should avoid like the plague — especially in meetings to be replaced home investing quotes stocks united states nspr overview compare quotes stock screener earnings calendar sectors nspr us nyse american join td ameritrade find a broker inspiremd inc watchlist createnspralert closed last updated jul    pm edt delayed quote     previous close  advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  k open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta  rev per employee k pe ratio na eps  yield na dividend na exdividend date na short interest k   of float shorted  average volume k performance  day   month   month  ytd   year  recent news marketwatch other dow jones us steel surges on strategic moves adobe slides after revenue miss sep   at  pm et by wallace witkowski the morning leverage yankee candle snuffs dividend plan jun   at  am et on the wall street journal recent news other news press releases inspiremds nspr ceo jim barry on q  results  earnings call transcript inspiremds nspr ceo jim barry on q  results  earnings call transcript may   at  pm et on seeking alpha q inspiremd inc q inspiremd inc may   at  pm et on edgar online  edg  q k inspiremd nspr investor presentation  slideshow mar   at  pm et on seeking alpha inspiremd almost gets there with best efforts equity offering raises m shares slip  mar   at  pm et on seeking alpha inspiremd down  on equity offering mar   at  pm et on seeking alpha longterm followup data show success of inspiremds cguard eps shares up  nov   at  pm et on seeking alpha q inspiremd inc aug   at  pm et on edgar online  edg  q k inspiremd prices equity offering shares down  jul   at  pm et on seeking alpha  growth stocks to buy near their week lows apr   at  am et on zackscom inspiremd reports q and fy results mar   at  am et on seeking alpha insiders roundup sales on facebook mar   at  pm et on gurufocuscom insiderinsightscom daily round up  codi ovas nspr flks mar   at  am et on seeking alpha new chief on the way at inspiremd jan   at  am et on seeking alpha the impact of a reverse stock split dec   at  am et on seeking alpha inspiremds nspr ceo alan milinazzo on q  results  earnings call transcript nov   at  pm et on seeking alpha inspiremds nspr ceo alan milinazzo on q  results  earnings call transcript aug   at  pm et on seeking alpha inspiremds nspr ceo alan milinazzo on q  results  earnings call transcript may   at  pm et on seeking alpha inspiremds nspr ceo alan milinazzo on q  results  earnings call transcript mar   at  pm et on seeking alpha inspiremd plunges on equity offer dilution mar   at  pm et on seeking alpha inspiremd inc nspr surges stock moves  higher  tale of the tape oct   at  am et on zackscom todays research report coverage on medical equipment stocks  novocure corindus vascular robotics inspiremd and nxstage medical todays research report coverage on medical equipment stocks  novocure corindus vascular robotics inspiremd and nxstage medical jul   at  am et on pr newswire  prf inspiremd announces completion of transition from exclusive european distributor to inspiremd managed local distribution network inspiremd announces completion of transition from exclusive european distributor to inspiremd managed local distribution network jun   at  am et on marketwired inspiremd to present at the  marcum microcap conference inspiremd to present at the  marcum microcap conference jun   at  am et on marketwired inspiremd announces distribution agreement for cguard eps in taiwan inspiremd announces distribution agreement for cguard eps in taiwan jun   at  am et on marketwired inspiremd announces the publication of an investigator initiated clinical registry reaffirming mguardtm prime as a highly effective tool to prevent heart damage in coronary artery blockages with high thrombotic content inspiremd announces the publication of an investigator initiated clinical registry reaffirming mguardtm prime as a highly effective tool to prevent heart damage in coronary artery blockages with high thrombotic content jun   at  am et on marketwired inspiremd announces distribution agreement for cguardtm eps in poland inspiremd announces distribution agreement for cguardtm eps in poland jun   at  am et on marketwired inspiremd announces appointment of paul stuka as chairman of the board inspiremd announces appointment of paul stuka as chairman of the board jun   at  am et on marketwired inspiremd to present at the th annual seethruequity microcap investor conference inspiremd to present at the th annual seethruequity microcap investor conference may   at  am et on accesswire inspiremd announces first two patients in hong kong successfully treated with cguard eps inspiremd announces first two patients in hong kong successfully treated with cguard eps may   at  am et on marketwired research reports initiation on medical equipment stocks  corindus vascular robotics inspiremd xtant medical and second sight medical products research reports initiation on medical equipment stocks  corindus vascular robotics inspiremd xtant medical and second sight medical products may   at  am et on pr newswire  prf inspiremds cguardtm carotid embolic prevention system featured in live case transmission at europcr  inspiremds cguardtm carotid embolic prevention system featured in live case transmission at europcr  may   at  am et on accesswire inspiremd announces publication of the ironguard registry in eurointervention inspiremd announces publication of the ironguard registry in eurointervention may   at  am et on accesswire inspiremd announces distribution agreements for cguardtm eps and mguard primetm eps in peru and ecuador inspiremd announces distribution agreements for cguardtm eps and mguard primetm eps in peru and ecuador may   at  am et on accesswire inspiremd provides business update for the first quarter of  inspiremd provides business update for the first quarter of  may   at  pm et on accesswire inspiremd schedules first quarter  earnings conference call inspiremd schedules first quarter  earnings conference call may   at  pm et on accesswire inspiremd announces distribution agreement for cguardtm eps in germany inspiremd announces distribution agreement for cguardtm eps in germany may   at  am et on accesswire inspiremd announces distribution agreement for cguardtm eps in the netherlands apr   at  am et on accesswire inspiremd announces listing of series b warrants on the nyse mkt apr   at  pm et on accesswire inspiremd announces distribution agreement for cguardtm in turkey apr   at  am et on accesswire inspiremd announces commercial launch of cguardtm eps in the russian federation at the icca stroke event in moscow mar   at  am et on accesswire inspiremd inc inspiremd inc is a medical device company which engages in the development and commercialization of the stent platform technology for the treatment of complex vascular and coronary disease its products are marketed for use mainly in patients with acute coronary syndromes notably acute myocardial infarction and saphenous vein graft coronary interventions the company was founded in  and is headquartered in tel aviv israel see full profile benzingas top initiations jan   at  am et on benzingacom competitors name chg  market cap spectranetics corp  b abbott laboratories  b boston scientific corp  b johnson  johnson  b stryker corp  b competitor data provided by partner content trending tickers powered by tsla  dvax  true  sq  chtr  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience nspr stock price  inspiremd inc stock quote us nyse american  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers algn  mhk  col  lyb  fls  mo  sbux  gt  latest newsall times eastern a breaking elon musk details tesla model  pricing range a tesla standard model  will cost  longrange model will cost   updated wall street isn’t ready for a point tumble in the dow industrials  barrons buzz robo  facebook and twitter trading on news  a wild week in washington  updated the dark side of cruises  trump to police dont be too nice  updated the highest paid athletes in the world in one chart  updated oj simpson made over  while in prison and won’t have to give any of it to the goldman family  updated here are  coworkers you should avoid like the plague — especially in meetings to be replaced home investing quotes stocks united states nspr overview compare quotes stock screener earnings calendar sectors nspr us nyse american join td ameritrade find a broker inspiremd inc watchlist createnspralert closed last updated jul    pm edt delayed quote     previous close  advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  k open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta  rev per employee k pe ratio na eps  yield na dividend na exdividend date na short interest k   of float shorted  average volume k performance  day   month   month  ytd   year  recent news marketwatch other dow jones us steel surges on strategic moves adobe slides after revenue miss sep   at  pm et by wallace witkowski the morning leverage yankee candle snuffs dividend plan jun   at  am et on the wall street journal recent news other news press releases inspiremds nspr ceo jim barry on q  results  earnings call transcript inspiremds nspr ceo jim barry on q  results  earnings call transcript may   at  pm et on seeking alpha q inspiremd inc q inspiremd inc may   at  pm et on edgar online  edg  q k inspiremd nspr investor presentation  slideshow mar   at  pm et on seeking alpha inspiremd almost gets there with best efforts equity offering raises m shares slip  mar   at  pm et on seeking alpha inspiremd down  on equity offering mar   at  pm et on seeking alpha longterm followup data show success of inspiremds cguard eps shares up  nov   at  pm et on seeking alpha q inspiremd inc aug   at  pm et on edgar online  edg  q k inspiremd prices equity offering shares down  jul   at  pm et on seeking alpha  growth stocks to buy near their week lows apr   at  am et on zackscom inspiremd reports q and fy results mar   at  am et on seeking alpha insiders roundup sales on facebook mar   at  pm et on gurufocuscom insiderinsightscom daily round up  codi ovas nspr flks mar   at  am et on seeking alpha new chief on the way at inspiremd jan   at  am et on seeking alpha the impact of a reverse stock split dec   at  am et on seeking alpha inspiremds nspr ceo alan milinazzo on q  results  earnings call transcript nov   at  pm et on seeking alpha inspiremds nspr ceo alan milinazzo on q  results  earnings call transcript aug   at  pm et on seeking alpha inspiremds nspr ceo alan milinazzo on q  results  earnings call transcript may   at  pm et on seeking alpha inspiremds nspr ceo alan milinazzo on q  results  earnings call transcript mar   at  pm et on seeking alpha inspiremd plunges on equity offer dilution mar   at  pm et on seeking alpha inspiremd inc nspr surges stock moves  higher  tale of the tape oct   at  am et on zackscom todays research report coverage on medical equipment stocks  novocure corindus vascular robotics inspiremd and nxstage medical todays research report coverage on medical equipment stocks  novocure corindus vascular robotics inspiremd and nxstage medical jul   at  am et on pr newswire  prf inspiremd announces completion of transition from exclusive european distributor to inspiremd managed local distribution network inspiremd announces completion of transition from exclusive european distributor to inspiremd managed local distribution network jun   at  am et on marketwired inspiremd to present at the  marcum microcap conference inspiremd to present at the  marcum microcap conference jun   at  am et on marketwired inspiremd announces distribution agreement for cguard eps in taiwan inspiremd announces distribution agreement for cguard eps in taiwan jun   at  am et on marketwired inspiremd announces the publication of an investigator initiated clinical registry reaffirming mguardtm prime as a highly effective tool to prevent heart damage in coronary artery blockages with high thrombotic content inspiremd announces the publication of an investigator initiated clinical registry reaffirming mguardtm prime as a highly effective tool to prevent heart damage in coronary artery blockages with high thrombotic content jun   at  am et on marketwired inspiremd announces distribution agreement for cguardtm eps in poland inspiremd announces distribution agreement for cguardtm eps in poland jun   at  am et on marketwired inspiremd announces appointment of paul stuka as chairman of the board inspiremd announces appointment of paul stuka as chairman of the board jun   at  am et on marketwired inspiremd to present at the th annual seethruequity microcap investor conference inspiremd to present at the th annual seethruequity microcap investor conference may   at  am et on accesswire inspiremd announces first two patients in hong kong successfully treated with cguard eps inspiremd announces first two patients in hong kong successfully treated with cguard eps may   at  am et on marketwired research reports initiation on medical equipment stocks  corindus vascular robotics inspiremd xtant medical and second sight medical products research reports initiation on medical equipment stocks  corindus vascular robotics inspiremd xtant medical and second sight medical products may   at  am et on pr newswire  prf inspiremds cguardtm carotid embolic prevention system featured in live case transmission at europcr  inspiremds cguardtm carotid embolic prevention system featured in live case transmission at europcr  may   at  am et on accesswire inspiremd announces publication of the ironguard registry in eurointervention inspiremd announces publication of the ironguard registry in eurointervention may   at  am et on accesswire inspiremd announces distribution agreements for cguardtm eps and mguard primetm eps in peru and ecuador inspiremd announces distribution agreements for cguardtm eps and mguard primetm eps in peru and ecuador may   at  am et on accesswire inspiremd provides business update for the first quarter of  inspiremd provides business update for the first quarter of  may   at  pm et on accesswire inspiremd schedules first quarter  earnings conference call inspiremd schedules first quarter  earnings conference call may   at  pm et on accesswire inspiremd announces distribution agreement for cguardtm eps in germany inspiremd announces distribution agreement for cguardtm eps in germany may   at  am et on accesswire inspiremd announces distribution agreement for cguardtm eps in the netherlands apr   at  am et on accesswire inspiremd announces listing of series b warrants on the nyse mkt apr   at  pm et on accesswire inspiremd announces distribution agreement for cguardtm in turkey apr   at  am et on accesswire inspiremd announces commercial launch of cguardtm eps in the russian federation at the icca stroke event in moscow mar   at  am et on accesswire inspiremd inc inspiremd inc is a medical device company which engages in the development and commercialization of the stent platform technology for the treatment of complex vascular and coronary disease its products are marketed for use mainly in patients with acute coronary syndromes notably acute myocardial infarction and saphenous vein graft coronary interventions the company was founded in  and is headquartered in tel aviv israel see full profile benzingas top initiations jan   at  am et on benzingacom competitors name chg  market cap spectranetics corp  b abbott laboratories  b boston scientific corp  b johnson  johnson  b stryker corp  b competitor data provided by partner content trending tickers powered by tsla  dvax  true  sq  chtr  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience flashratings  about us facebook autocomplete demo post a rating  month price target   trending sign up log in flashratings  all research for my stocks the most comprehensive equity research coverage available online never miss a single piece of research upgrade downgrade or target price change by any analyst firm on any stock equity research by professional analysts  especially their rationales more than their forecasts  contains far more interesting and important information about the actual fundamentals of the traded companies than can be gathered from conventional news reports our mission is to unlock access to valuable research on stocks for all retail investors professionals institutions take advantage of our costeffective subscriptions to have flashratingss comprehensive realtime feed delivered into your intranet and trading floor platforms institutional subscriptions websites become a content licensing partner and display flashratingss popular news feed on your website content licensing advertisers advertise with us and have flashratings readers with attractive demographics take advantage of your products advertising flashratings  principles facebook autocomplete demo post a rating  month price target   trending sign up log in flashratings principles  flashratings mission is to provide you  the investor  with as much honest and professional research on your investments as possible  we believe its much better to get a multitude of credible opinions on an investment than to arbitrarily follow any single advisor  be it your banker a friend or a tv pundit  flashratings does not provide advice our job is to accurately and objectively report on analysts credible research and opinions the only advice flashratings will ever give you is to absorb as much fundamental research and different opinions as possible and make your own decisions  flashratings favors covering analysts with proven track records but will cover all analysts as long as their research is honest and professional sign up » microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft inspiremd inc nspr  product pipeline analysis  update about us solutions resources ebookswhite papers slideshares videos blog contact us register log in my account logout browse research my cart menu   close   x browse about us solutions resources contact us log out register log in life sciences»medical devices»medical devices company reports inspiremd inc nspr  product pipeline analysis  update lowest prices guaranteed length publisher published date sku from   pages globaldata june  gbdt lowest prices guaranteed price from  length  pages publisher globaldata published date june  sku gbdt table of contents close window table of contents inspiremd inc nspr  product pipeline analysis  update printer format globaldata inspiremd inc company snapshot inspiremd inc company overview inspiremd inc pipeline products and clinical trials overview inspiremd inc – pipeline analysis overview key facts inspiremd inc  major products and services inspiremd inc pipeline products by development stage inspiremd inc clinical trials by trial status inspiremd inc pipeline products overview cguard embolic protection system cguard embolic protection system product overview cguard embolic protection system clinical trial mguard drug eluting stent mguard drug eluting stent product overview mguard embolic protection stent mguard embolic protection stent product overview mguard prime eps mguard prime eps product overview nvguard neurovascular nvguard neurovascular product overview pvguard peripheral pvguard peripheral product overview rguard renal rguard renal product overview inspiremd inc  key competitors inspiremd inc  key employees inspiremd inc  locations and subsidiaries head office other locations  subsidiaries recent developments inspiremd inc recent developments may   inspiremd reports financial results for the first quarter ended march   may   inspiremd announces latebreaking trial presentation on cguard embolic prevention system at europcr  conference mar   inspiremd reports financial results for the fourth quarter and year ended december   jan   inspiremd aligns operations and leadership team appoints isaac blech as vice chairman of the board dec   inspiremd receives eu regulatory approval for additional supplier of cguard delivery catheters nov   inspiremd announces positive twelve month followup carenet trial data at veith symposium  nov   inspiremd reports financial results for the third quarter ended september   oct   inspiremd announces cguard approval in argentina oct   inspiremd announces cguard approval in columbia sep   inspiremd announces full market launch of cguard distributed by penumbra at cirse annual congress appendix methodology about globaldata contact us disclaimer list of tablesinspiremd inc pipeline products and clinical trials overview inspiremd inc pipeline products by equipment type inspiremd inc pipeline products by indication inspiremd inc clinical trials by trial status inspiremd inc key facts inspiremd inc major products and services inspiremd inc number of pipeline products by development stage inspiremd inc pipeline products summary by development stage inspiremd inc clinical trials by trial status inspiremd inc clinical trials summary cguard embolic protection system  product status cguard embolic protection system  product description cguard embolic protection system  prospective evaluation of allcomer percutaneous carotid revascularization in symptomatic and increasedrisk asymptomatic carotid artery stenosis mguard drug eluting stent  product status mguard drug eluting stent  product description mguard embolic protection stent  product status mguard embolic protection stent  product description mguard prime eps  product status mguard prime eps  product description nvguard neurovascular  product status nvguard neurovascular  product description pvguard peripheral  product status pvguard peripheral  product description rguard renal  product status rguard renal  product description inspiremd inc key employees inspiremd inc other locations list of figuresinspiremd inc pipeline products by equipment type inspiremd inc pipeline products by development stage inspiremd inc clinical trials by trial status description close window description inspiremd inc nspr  product pipeline analysis  update printer format globaldata summaryinspiremd inc inspiremd formerly saguaro resources inc is a medical device company that offers technology products the company develops and commercializes stent platform mguard technology its mguard is based on net that is wrapped with an expandable micronet inspiremd uses mguard technology develops products that are applied in interventional cardiology and other vascular procedures the company offers mguard prime which include mesh sleeve wrapped around a cobaltchromium stent it utilizes its technology to make products and offers solutions for various disease conditions such as stenting embolic showers restenosis and late stent thrombosis the company sells its products through a network of distributors in israel and germany inspiremd is headquartered in boston massachusetts the usthis report is a source for data analysis and actionable intelligence on the company’s portfolio of pipeline products the report provides key information about the company its major products and brands the report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantagescopethe report reviews detailed company profile with information on business description key company facts major products and services key competitors key employees locations and subsidiaries and recent developmentsthe report analyzes all pipeline products in development for the company inspiremd incthe report provides pipeline analysis on all pipeline products of the company by equipment type by indication by development stage and by trial statusthe report covers detailed information on each pipeline product with information on pipeline territory stage of development device class regulatory path indications applications and estimated launch datethe report provides detailed description of products in development technical specification and functionsthe report also covers ongoing clinical trials wherever applicable with information on trial name trial objective sponsor trial design  trial status and phase estimated start and end datereasons to buydevelop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscapedesign and develop your product development marketing and sales strategies by understanding the competitor portfolioto formulate effective research  development strategiesdevelop marketentry and market expansion strategiesexploit inlicensing and outlicensing opportunities by identifying products most likely to ensure a robust returnplan mergers and acquisitions effectively by identifying key players of the most promising pipeline identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantagedevelop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials stage and of development etcidentify understand and capitalize the next highvalue products that your competitor would add in its portfolio search inside this report close window search inside this report online download  purchase site license  purchase global site license  purchase   research assistance us  intl  download our ebook how to succeed using market research learn how to effectively navigate the market research process to help guide your organization on the journey to success download ebook share this report other tasks printer format order by fax currency converter facebook autocomplete demo post a rating  month price target   home trending sign up log in analyst ranking   name measured ratings sucess rate avg return  mizuho      credit suisse      jefferies      cantor fitzgerald      bank of america merrill lynch      jmp securities      goldman sachs      raymond james      fbr capital markets      william blair     distributor zone  inspiremd home  distributor zone distributor zone this content is restricted to inspiremd distributors to become a distributor please contact us at salesinspiremdcom existing users log inusernamepassword remember me  forgot password click here to resetnew user click here to register flashratings  contact us facebook autocomplete demo post a rating  month price target   trending sign up log in contact flashratings your emotional state excited confused worried upset panicked angry inspiremd inc nspra company profile  reuterscom x edition united states africa américa latina عربي argentina brasil canada  deutschland españa france india italia  méxico россия united kingdom united states profile inspiremd inc nspra related topics stocksstock screenerhealthcaremedical equipment supplies  distribution overview news key developments people charts financials analysts research pulse nspra on american stock exchange usd  jul  change  chg   prev close  open  days high  days low  volume  avg vol  wk high  wk low  full description inspiremd inc incorporated on february   is a medical device company the company is focusing on the development and commercialization of its micronet stent platform technology for the treatment of vascular and coronary disease its micronet a micron mesh sleeve is wrapped over a stent to provide embolic protection in stenting procedures its cguard carotid embolic prevention system cguard eps combines its micronet and a selfexpandable nitinol stent in a single device for use in carotid artery applications its mguard prime embolic protection system mguard prime eps is marketed for use in patients with acute coronary syndromes notably acute myocardial infarction heart attack and saphenous vein graft coronary interventions bypass surgery it markets and sells mguard prime eps a baremetal cobaltchromium based stent for the treatment of coronary disease in the european unionthe company is also developing a neurovascular flow diverter nguard which is an endovascular device that directs blood flow away from cerebral aneurysms in order to seal the aneurysms it is also focusing on developing a pipeline of other products and additional applications by leveraging its micronet technology to applications to develop peripheral vascular and neurovascular procedures such as the treatment of the superficial femoral artery disease vascular disease below the knee and neurovascular stenting to open diseased vessels in the brain the companys mguard prime eps coronary product comprises micronet wrapped around a cobaltchromium based baremetal stent the mguard prime eps is integrated with an engineered micro net mesh that is designed to prevent the unstable arterial plaque and thrombus that caused the heart attack blockage from breaking offthe company competes with abbott laboratories boston scientific corporation medtronic plc cardinal health inc gore medical terumo corporation stryker corporation johnson  johnson penumbra inc merit medical systems inc w l gore  associates inc microport scientific corporation and medikit co ltd » full overview of nspra company address inspiremd inc  menorat hamaor sttel avivyafo   ma    p f  company web links home page officers  directors name compensation paul stuka  james barry  isaac blech  craig shore  agustin gago  » more officers  directors inspiremd inc news briefinspiremd signed distribution agreements for cguard eps with comesa gmbh jun   briefinspiremd announces distribution agreement for cguard eps in taiwan jun   briefinspiremd announces distribution agreement for cguard eps in poland jun   briefinspiremd announces appointment of paul stuka as chairman of board jun   briefinspiremd inc q revenue  may   » more nspra news related topics stocksstock screenerhealthcaremedical equipment supplies  distribution inspiremd inc nspr  product pipeline analysis  update infowiseguyreportscom     chat with us           us         uk login register home report categories premium reports access to  premium reports aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports report categories aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports publisher knowledgestore countries browse by country browse by continent browse by group  region conferences upcoming conferences seminars conferences upcoming conferences seminars countries browse by country browse by continent browse by group  region news  blog press release blog news  blogs press release blogs faqs about us about our company our team life at wgr careers contact us there are no items currently in your basket there are no items currently in your basket search home all reports inspiremd inc nspr  product pipeline analysis   inspiremd inc nspr  product pipeline analysis  update wgr  may  global  pages globaldata description table of content sample report enquiry before buy related reports summaryinspiremd inc inspiremd is a medical device manufacturer it focuses on the development and commercialization of stent platform technology mguard the company by using its mguard technology develops products that are used in interventional cardiology and other vascular procedures the company’s mguard is based on net and which is wrapped with an expandable micronet mesh its mguard prime includes mesh sleeve wrapped around a cobaltchromium stent inspiremd’s utilizes its technology to make products and offers solutions for various disease conditions such as stenting embolic showers restenosis and late stent thrombosis it sells its products through distributors in israel and germany inspiremd is headquartered in tel aviv israelthis report is a source for data analysis and actionable intelligence on the company’s portfolio of pipeline products the report provides key information about the company its major products and brands the report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantagescope the report reviews detailed company profile with information on business description key company facts major products and services key competitors key employees locations and subsidiaries and recent developments the report analyzes all pipeline products in development for the company inspiremd inc the report provides pipeline analysis on all pipeline products of the company by equipment type by indication by development stage and by trial status the report covers detailed information on each pipeline product with information on pipeline territory stage of development device class regulatory path indications applications and estimated launch date the report provides detailed description of products in development technical specification and functions the report also covers ongoing clinical trials wherever applicable with information on trial name trial objective sponsor trial design  trial status and phase estimated start and end datereasons to buy develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape design and develop your product development marketing and sales strategies by understanding the competitor portfolio to formulate effective research  development strategies develop marketentry and market expansion strategies exploit inlicensing and outlicensing opportunities by identifying products most likely to ensure a robust return plan mergers and acquisitions effectively by identifying key players of the most promising pipeline  identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials stage and of development etc identify understand and capitalize the next highvalue products that your competitor would add in its portfolio table of contents table of contents list of tables list of figures inspiremd inc company snapshot inspiremd inc company overview key information inspiremd inc pipeline products and clinical trials overview inspiremd inc – pipeline analysis overview key facts inspiremd inc  major products and services inspiremd inc pipeline products by development stage inspiremd inc clinical trials by trial status inspiremd inc pipeline products overview mguard carotid mguard carotid product overview mguard cerebral aneurysm mguard cerebral aneurysm product overview mguard drug eluting stent mguard drug eluting stent product overview mguard embolic protection stent mguard embolic protection stent product overview mguard embolic protection stent clinical trial mguard peripheral mguard peripheral product overview mguard prime mguard prime product overview mguard renal mguard renal product overview inspiremd inc  key competitors inspiremd inc  key employees inspiremd inc  locations and subsidiaries head office other locations  subsidiaries recent developments inspiremd inc recent developments may   inspiremd reports financial results for the first quarter ended march   may   inspiremd announces positive results from imos prime registry for the mguard prime eps apr   inspiremd announces voluntary field action for mguard prime eps mar   inspiremd announces first patient enrolled into new cguard carenet carotid embolic protection study using micronet clinical trial feb   inspiremd reports financial results for the quarter and six month period ended december   feb   inspiremd reports successful implantation of the new cguard carotid embolic system with micronet technology dec   inspiremd to present at the th annual oppenheimer  co healthcare conference in new york city on december th dec   inspiremd appoints rick olson as vice president of global sales operations nov   inspiremd announces upcoming investor event in israel nov   inspiremd reports financial results for quarter ended september   appendix methodology about globaldata contact us disclaimer list of tables inspiremd inc key facts inspiremd inc pipeline products and clinical trials overview inspiremd inc pipeline products by equipment type inspiremd inc pipeline products by indication inspiremd inc clinical trials by trial status inspiremd inc key facts inspiremd inc major products and services inspiremd inc number of pipeline products by development stage inspiremd inc pipeline products summary by development stage inspiremd inc clinical trials by trial status inspiremd inc clinical trials summary mguard carotid  product status mguard carotid  product description mguard cerebral aneurysm  product status mguard cerebral aneurysm  product description mguard drug eluting stent  product status mguard drug eluting stent  product description mguard embolic protection stent  product status mguard embolic protection stent  product description mguard embolic protection stent  efficacy study of mguard coronary stent in patients suffering from stsegment elevation myocardial infarction mguard embolic protection stent  mguard in svg and native coronaries trial mguard embolic protection stent  mguard versus baremetal stents plus manual thrombectomy in real world stemi patients a prospective multicenter randomized trial mguard peripheral  product status mguard peripheral  product description mguard prime  product status mguard prime  product description mguard renal  product status mguard renal  product description inspiremd inc key employees inspiremd inc other locations list of figures inspiremd inc pipeline products by equipment type inspiremd inc pipeline products by development stage inspiremd inc clinical trials by trial status  request a sample report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro do you have any specific field of interest confirm make an enquiry before buying this report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro your enquiry confirm purchase this market research report usd gbp euro yen inr user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  add to cart buy now   email report   sample report   save page   any questions   download information   check discount   download order form   email report   sample report   save page   any questions   download information   check discount   download order form contact us akash anand domain head business development saleswiseguyreportscom     us     uk rishabh arora domain head business development saleswiseguyreportscom  abu koshy domain head business development saleswiseguyreportscom     related reports × tell a friend about this report your name your email friends name friends email your enquiry send general page  inspiremd home  general page general page sub title text  at ut officium eatium explab intiae inisit plabor re conet pa porest esequi audae con eaquis sumet dolupta temperum et quunt vendipit eventoreror a et aut loty moret uptas etusam faccum ad quas eos dem fugita voluptasitas ut faci unt qui archili tatust apis volorest hilibusdam dolendignate voles alique ped es exerae ut aut exerci susam fuga nem ut dollaut enecae sit simusantius quaspie ndistia pernam nonecti usdanda nimusap elibusda voluptio tem hariorruptat harum quasinis ducimolor sit atempor rovidig entiunt harupta turita destrun totatem harum qui dem nia commoluptat mus eosaect uribere cus aperiorum hari omnisi rae nos et eos estem liatia sus tem quideli tiorerror solut poriaec tinctur quosten deniaeperum el et reprepel inctatemos ut aria sequi volupturest quam quae molesto et voluptatur si omnis eaqui as a volor ra dolor ad etur sitassum hici cum idus dit prate sunte vid est vollorrum ent aligendit hil inctur tendenimus ea vitatiosant ernatur ulpa doloria tureicabor asitiatem que nos doluptatur si ium aborum aut la dunti dignis nobis et volupta vit ium qui sitatur sit exere natus et exero occulla ceatem que et volor ad qui od mo consenis a sapitia eprore doluptas ariaspid molore aditiorunt re ipsus quae vellec   sub title text  tendenimus ea vitatiosant ernatur ulpa doloria tureicabor asitiatem que nos doluptatur si ium aborum aut la dunti dignis nobis et volupta vit ium qui sitatur sit exere natus et exero occulla ceatem que et volor ad qui od mo consenis a sapitia eprore doluptas ariaspid molore aditiorunt re ipsus quae vellec side bar  item goes here item goes here item goes here side bar  item goes here item goes here item goes here inspiremd inc  nspr  stock price today  zacks quote overview stock activity open  day low  day high   wk low   wk high  avg volume  market cap  m dividend    beta  key earnings data earnings esp  most accurate est na current qtr est na current yr est na exp earnings date  prior year eps  exp eps growth yrna forward pe na peg ratio na medical » medical  instruments zacks earnings esp expected surprise prediction looks to find earnings surprises by focusing on the most recent analyst revisions this is done because generally speaking if an analyst reevaluates their earnings estimate right before an earnings release it means that they have fresh information which could potentially be more accurate than what analysts thought about a company two or three months ago the crux of this approach is comparing the most accurate estimate to the zacks consensus estimate although the zacks rank is also an important feature of the esp metric combining these two can help investors find stocks that are ready to beat the consensus at their next report and hopefully surge higher in price too in fact when combining a zacks rank  or better and a positive earnings esp stocks produced a positive surprise  of the time and best of all by using these parameters investors have seen  annual returns on average according to our  year backtest visit the earnings esp center see the full list of stocks to beat earnings premium research for nspr zacks rank na zacks industry rank bottom  out of  zacks sector rank bottom   out of  style scores na value  na growth  na momentum  na vgm earnings esp  research report for nspr snapshot this is our short term rating system that serves as a timeliness indicator for stocks over the next  to  months how good is it see rankings and related performance below zacks rank definition annualized return  strong buy   buy   hold   sell   strong sell  sp   zacks rank education  learn more about the zacks rank zacks rank home  all zacks rank resources in one place zacks premium  the only way to get access to the zacks rank the style scores are a complementary set of indicators to use alongside the zacks rank it allows the user to better focus on the stocks that are the best fit for his or her personal trading style the scores are based on the trading styles of value growth and momentum theres also a vgm score v for value g for growth and m for momentum which combines the weighted average of the individual style scores into one score value score a growth score a momentum score a vgm score a within each score stocks are graded into five groups a b c d and f as you might remember from your school days an a is better than a b a b is better than a c a c is better than a d and a d is better than an f as an investor you want to buy stocks with the highest probability of success that means you want to buy stocks with a zacks rank  or  strong buy or buy which also has a score of an a or a b in your personal trading style zacks style scores education  learn more about the zacks style scores the zacks industry rank assigns a rating to each of the  x expanded industries based on their average zacks rank an industry with a larger percentage of zacks rank s and s will have a better average zacks rank than one with a larger percentage of zacks rank s and s the industry with the best average zacks rank would be considered the top industry  out of  which would place it in the top  of zacks ranked industries the industry with the worst average zacks rank  out of  would place in the bottom  zacks rank education  learn more about the zacks rank zacks industry rank education  learn more about the zacks industry rank the zacks sector rank assigns a rating to each of the  sectors based on their average zacks rank a sector with a larger percentage of zacks rank s and s will have a better average zacks rank than one with a larger percentage of zacks rank s and s zacks sector rank education  learn more about the zacks sector rank the sector with the best average zacks rank would be considered the top sector  out of  which would place it in the top  of zacks ranked sectors the sector with the worst average zacks rank  out of  would place in the bottom  zacks rank education  learn more about the zacks rank zacks sector rank education  learn more about the zacks sector rank the zacks equity research reports or zer for short are our inhouse independently produced research reports the ever popular onepage snapshot reports are generated for virtually every single zacks ranked stock its packed with all of the companys key stats and salient decision making information including the zacks rank zacks industry rank style scores the price consensus  surprise chart graphical estimate analysis and how a stocks stacks up to its peers the detailed multipage analyst report does an even deeper dive on the companys vital statistics in addition to all of the proprietary analysis in the snapshot the report also visually displays the four components of the zacks rank agreement magnitude upside and surprise provides a comprehensive overview of the company business drivers complete with earnings and sales charts a recap of their last earnings report and a bulleted list of reasons to buy or sell the stock it also includes an industry comparison table to see how your stock compares to its expanded industry and the sp  researching stocks has never been so easy or insightful as with the zer analyst and snapshot reports learn more about zacks equity research reports see more zacks equity research reports zacks earnings esp expected surprise prediction looks to find companies that have recently seen positive earnings estimate revision activity the idea is that more recent information is generally speaking more accurate and can be a better predictor of the future which can give investors an advantage in earnings season the technique has proven to be very useful for finding positive surprises in fact when combining a zacks rank  or better and a positive earnings esp stocks produced a positive surprise  of the time while they also saw  annual returns on average according to our  year backtest visit the earnings esp center see the full list of stocks to beat earnings this is our short term rating system that serves as a timeliness indicator for stocks over the next  to  months how good is it see rankings and related performance below zacks rank definition annualized return  strong buy   buy   hold   sell   strong sell  sp   zacks rank education  learn more about the zacks rank zacks rank home  all zacks rank resources in one place zacks premium  the only way to fully access the zacks rank the zacks industry rank assigns a rating to each of the  x expanded industries based on their average zacks rank an industry with a larger percentage of zacks rank s and s will have a better average zacks rank than one with a larger percentage of zacks rank s and s the industry with the best average zacks rank would be considered the top industry  out of  which would place it in the top  of zacks ranked industries the industry with the worst average zacks rank  out of  would place in the bottom  zacks rank education  learn more about the zacks rank zacks industry rank education  learn more about the zacks industry rank the zacks sector rank assigns a rating to each of the  sectors based on their average zacks rank a sector with a larger percentage of zacks rank s and s will have a better average zacks rank than one with a larger percentage of zacks rank s and s zacks sector rank education  learn more about the zacks sector rank the sector with the best average zacks rank would be considered the top sector  out of  which would place it in the top  of zacks ranked sectors the sector with the worst average zacks rank  out of  would place in the bottom  zacks rank education  learn more about the zacks rank zacks sector rank education  learn more about the zacks sector rank the style scores are a complementary set of indicators to use alongside the zacks rank it allows the user to better focus on the stocks that are the best fit for his or her personal trading style the three scores are based on the trading styles of growth value and momentum growth score a value score a momentum score a within each score stocks are graded into five groups a b c d and f as you might remember from your school days an a is better than a b a b is better than a c a c is better than a d and a d is better than an f as an investor you want to buy stocks with the highest probability of success that means you want to buy stocks with a zacks rank  or  strong buy or buy which also has a score of an a or a b zacks style scores education  learn more about the zacks style scores the style scores are a complementary set of indicators to use alongside the zacks rank it allows the user to better focus on the stocks that are the best fit for his or her personal trading style the scores are based on the trading styles of value growth and momentum theres also a vgm score v for value g for growth and m for momentum which combines the weighted average of the individual style scores into one score value score a growth score a momentum score a vgm score a within each score stocks are graded into five groups a b c d and f as you might remember from your school days an a is better than a b a b is better than a c a c is better than a d and a d is better than an f as an investor you want to buy stocks with the highest probability of success that means you want to buy stocks with a zacks rank  or  strong buy or buy which also has a score of an a or a b in your personal trading style zacks style scores education  learn more about the zacks style scores the zacks equity research reports or zer for short are our inhouse independently produced research reports the ever popular onepage snapshot reports are generated for virtually every single zacks ranked stock its packed with all of the companys key stats and salient decision making information including the zacks rank zacks industry rank style scores the price consensus  surprise chart graphical estimate analysis and how a stocks stacks up to its peers the detailed multipage analyst report does an even deeper dive on the companys vital statistics in addition to all of the proprietary analysis in the snapshot the report also visually displays the four components of the zacks rank agreement magnitude upside and surprise provides a comprehensive overview of the company business drivers complete with earnings and sales charts a recap of their last earnings report and a bulleted list of reasons to buy or sell the stock it also includes an industry comparison table to see how your stock compares to its expanded industry and the sp  researching stocks has never been so easy or insightful as with the zer analyst and snapshot reports learn more about zacks equity research reports see more zacks equity research reports   change in last  days view all zacks rank  strong buys premium research industry analysis top peers symbol zacks rank inspiremd inc nspr na fresenius medical care corporation fms abiomed inc abmd conformis inc cfms corindus vascular robotics inc cvrs cryolife inc cry dextera surgical inc dxtr see all medical  instruments peers zacks news for nspr no record found company summary inspiremd inc is a medical device company focusing on the development and commercialization of its proprietary stent system technology mguardtm the companys initial products are marketed for use mainly in patients with acute coronary syndromes notably acute myocardial infarction and saphenous vein graft coronary interventions it focuses on applying its technology to develop additional products used for other vascular procedures specifically carotid and peripheral procedures inspiremd inc is headquartered in tel aviv israel medical devices market research reports  medical devices industry analysis  marketresearchcom about us solutions resources ebookswhite papers slideshares videos blog contact us register log in my account logout browse research my cart menu   close   x browse about us solutions resources contact us log out register log in market research » life sciences medical devices market research reports  industry analysis medical devices are durable and disposable in nature these devices can be used for a wide variety of conditions for surgical procedures home health care clinical settings or in the medical office setting a medical device is an instrument apparatus implant in vitro reagent or anything similar which can be used to diagnose prevent or treat a disease within the body it can be as simple as a tongue depressor medical thermometer or disposable gloves it can also be as complex as a computer which can assist in medical testing an implant like a stent or a prosthesis globally the medical device market is over  billion medical devices are classified in one of three regulatory classes the classification is dependent on the intended use of the device and indications for use the us accounts for approximately  of the global medical device market china japan russia and brazil have the most stringent regulatory compliance for medical devices research can be found within market research industry reports which will further outline economic industry trends device regulation globally and challenges facing medical device leaders show more show less filter your search filter your search aesthetic devices  cosmetic surgery  anesthesia  blood  cardiac rhythm management  cardiovascular devices  catheters  country overviews  critical care  dental equipment  diabetes  dialysis  disposables  drug delivery systems  durable medical equipment  electronics  endoscopy  ent  equipment  supplies  general medical devices  gynecological devices  home health  implantable devices  information technology  infusion products  manufacturing  packaging  materials science  medical devices  medical devices company reports  medical laser  minimally invasive surgery  needles syringes iv access  neurology devices  ophthalmic devices  orthopedics  patient monitoring  regulation  respiratory devices  stents  sterilization equipment  surgical equipment  urology  virtual reality  wearable medical devices  wound care  global  asia  europe  north america  south america  oceania  africa  middle east  caribbean  central america  research assistance us  intl  join alert me now receive biweekly email alerts on new research sign up find out more on our blog medical devices industry research  market reports sort by title az title za price lowtohigh price hightolow date date older first refine your search close window refine your search title publisher keyword priceusd to date any date last month last  months last  months last year last  years region all regions africa    algeria    angola    benin    botswana    burkina faso    burundi    cameroon    cape verde    central african republic    chad    comoros    the congo    the congo    cote divoire    djibouti    egypt    equatorial guinea    eritrea    ethiopia    gabon    the gambia    ghana    guinea    guineabissau    kenya    lesotho    liberia    libya    madagascar    malawi    mali    mauritania    mauritius    mayotte    morocco    mozambique    namibia    niger    nigeria    reunion    rwanda    sao tome and principe    senegal    seychelles    sierra leone    somalia    south africa    south sudan    sudan    swaziland    tanzania    togo    tunisia    uganda    western sahara    zambia    zimbabwe asia    afghanistan    armenia    azerbaijan    bangladesh    bhutan    brunei    cambodia    china    cocos keeling islands    east timor    georgia    hong kong    india    indonesia    japan    kazakhstan    kyrgyzstan    laos    macau    malaysia    maldives    mongolia    myanmar    nepal    north korea    pakistan    papua new guinea    philippines    russia    singapore    south korea    sri lanka    taiwan    tajikistan    thailand    turkey    turkmenistan    uzbekistan    vietnam caribbean    anguilla    antigua and barbuda    aruba    the bahamas    barbados    british virgin islands    cayman islands    cuba    curacao    dominica    dominican republic    grenada    guadeloupe    haiti    jamaica    martinique    montserrat    netherlands antilles    puerto rico    saint kitts and nevis    saint lucia    saint vincent and the grenadines    sint maarten saint maarten    trinidad and tobago    turks and caicos islands    virgin islands central america    belize    costa rica    el salvador    guatemala    honduras    nicaragua    panama europe    albania    andorra    austria    belarus    belgium    bosnia and herzegovina    bulgaria    croatia    czech republic    denmark    estonia    faroe islands    finland    france    germany    gibraltar    greece    guernsey    hungary    iceland    ireland    isle of man    italy    jersey    kosovo    latvia    liechtenstein    lithuania    luxembourg    macedonia    malta    moldova    monaco    netherlands    norway    poland    portugal    romania    san marino    scotland    serbia and montenegro    slovakia    slovenia    spain    sweden    switzerland    ukraine    united kingdom global middle east    bahrain    cyprus    gaza strip    iran    iraq    israel    jordan    kuwait    lebanon    oman    palestinian territories    qatar    saudi arabia    syria    united arab emirates    yemen north america    bermuda    canada    greenland    mexico    united states oceania    american samoa    australia    cook islands    fiji    french polynesia    guam    kiribati    marshall islands    micronesia federated states of    nauru    new caledonia    new zealand    niue    norfolk island    northern mariana islands    palau    samoa    solomon islands    tonga    tuvalu    vanuatu south america    argentina    bolivia    brazil    chile    colombia    ecuador    falkland islands    french guiana    guyana    paraguay    peru    suriname    uruguay    venezuela search france central venous catheters market outlook to  aug    usd  value in millions of us dollars volume in units and average prices usd within market segments  antimicrobial central venous catheters non antimicrobial central venous catheters and picc peripherally inserted central catheter lines the report  read more global medical aesthetics industry injectables energybased devices cosmeceuticals cosmetic surgery facial aesthetics implants cosmetic tourism market analysis  forecast to  aug    usd  cosmetic surgery facial aesthetics implants cosmetic tourism market analysis  forecast to  published august  is a most comprehensive analysis on this vertically growing market this detailed report provides strategic business development information and  read more germany central venous catheters market outlook to  aug    usd  value in millions of us dollars volume in units and average prices usd within market segments  antimicrobial central venous catheters non antimicrobial central venous catheters and picc peripherally inserted central catheter lines the report  read more blood purification equipment  medical devices pipeline assessment  aug    usd  stage the report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development the report reviews major players involved in the pipeline product development it also provides  read more italy central venous catheters market outlook to  aug    usd  value in millions of us dollars volume in units and average prices usd within market segments  antimicrobial central venous catheters non antimicrobial central venous catheters and picc peripherally inserted central catheter lines the report  read more south korea central venous catheters market outlook to  aug    usd  the report provides value in millions of us dollars volume in units and average prices usd within market segments  antimicrobial central venous catheters non antimicrobial central venous catheters and picc peripherally inserted central catheter  read more contact lenses  medical devices pipeline assessment  aug    usd  provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development the report reviews major players involved in the pipeline product development it also provides information about clinical  read more japan central venous catheters market outlook to  aug    usd  value in millions of us dollars volume in units and average prices usd within market segments  antimicrobial central venous catheters non antimicrobial central venous catheters and picc peripherally inserted central catheter lines the report  read more canada central venous catheters market outlook to  aug    usd  value in millions of us dollars volume in units and average prices usd within market segments  antimicrobial central venous catheters non antimicrobial central venous catheters and picc peripherally inserted central catheter lines the report  read more russia central venous catheters market outlook to  aug    usd  value in millions of us dollars volume in units and average prices usd within market segments  antimicrobial central venous catheters non antimicrobial central venous catheters and picc peripherally inserted central catheter lines the report  read more australia central venous catheters market outlook to  aug    usd  value in millions of us dollars volume in units and average prices usd within market segments  antimicrobial central venous catheters non antimicrobial central venous catheters and picc peripherally inserted central catheter lines the report  read more peripheral embolic protection devices  medical devices pipeline assessment  aug    usd  currently in pipeline stage the report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development the report reviews major players involved in the pipeline product development  read more china central venous catheters market outlook to  aug    usd  value in millions of us dollars volume in units and average prices usd within market segments  antimicrobial central venous catheters non antimicrobial central venous catheters and picc peripherally inserted central catheter lines the report  read more india central venous catheters market outlook to  aug    usd  value in millions of us dollars volume in units and average prices usd within market segments  antimicrobial central venous catheters non antimicrobial central venous catheters and picc peripherally inserted central catheter lines the report  read more mexico central venous catheters market outlook to  aug    usd  value in millions of us dollars volume in units and average prices usd within market segments  antimicrobial central venous catheters non antimicrobial central venous catheters and picc peripherally inserted central catheter lines the report  read more arteriotomy closure devices  medical devices pipeline assessment  aug    usd  stage the report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development the report reviews major players involved in the pipeline product development it also provides  read more arthroscopy  medical devices pipeline assessment  aug    usd  on the pipeline products with comparative analysis of the products at various stages of development the report reviews major players involved in the pipeline product development it also provides information about clinical trials in progress  read more shoulder replacement  medical devices pipeline assessment  aug    usd  provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development the report reviews major players involved in the pipeline product development it also provides information about clinical  read more united states central venous catheters market outlook to  aug    usd  the report provides value in millions of us dollars volume in units and average prices usd within market segments  antimicrobial central venous catheters non antimicrobial central venous catheters and picc peripherally inserted central catheter  read more united kingdom central venous catheters market outlook to  aug    usd  the report provides value in millions of us dollars volume in units and average prices usd within market segments  antimicrobial central venous catheters non antimicrobial central venous catheters and picc peripherally inserted central catheter  read more brazil central venous catheters market outlook to  aug    usd  value in millions of us dollars volume in units and average prices usd within market segments  antimicrobial central venous catheters non antimicrobial central venous catheters and picc peripherally inserted central catheter lines the report  read more spain central venous catheters market outlook to  aug    usd  value in millions of us dollars volume in units and average prices usd within market segments  antimicrobial central venous catheters non antimicrobial central venous catheters and picc peripherally inserted central catheter lines the report  read more liquid handling system market by type electronic automated manual product pipette consumables workstation microplate dispensers burette application drug discovery genomics clinical diagnostics proteomics  end user  forecast to  jul    usd  systems market is expected to reach usd  billion by  at a cagr of  rapidly developing global biotechnology and pharmaceutical industries rising requirement for highthroughput screening hts increasing emphasis on data precision and  read more medical tapes and bandages market by product tapes fabric paper plastic bandage gauze adhesive cohesive  elastic application surgery trauma  laceration ulcer sport burns end user hospitals ascs clinics homecare  forecast to  jul    usd   medical tapes and medical bandages market projected to grow at a cagr of  the global medical tapes and medical bandages market is projected to reach usd  billion by  from usd   read more urology devices global market jul    usd  devices due to advantages such as fewer incisions faster recovery rate and less hospital stays compared to open surgical intervention present trend in this market is development and usage of nextgeneration urology devices like laser  read more  prev           next  start new browse consumer goods food  beverage heavy industry life sciences marketing  market research public sector service industries technology  media company reports reports by country view all market areas view all publishers market report inspiremd inc nspr  product pipeline analysis  update about us • publishers • contact us • cart login  register all industries business  finance  business  financial services  insurance  marketing consumer  food  beverages  consumer goods  food  retailing healthcare  biotechnology  healthcare  medical devices  pharmaceuticals heavy industry  construction  energy  manufacturing  materials  transportation internet  media  ebusiness  internet  media  publishing public sector  defense  education  government telecom  computing  computer technology  fixed networks  software  wireless companycountry reports  company reports  country reports  regional reports   processing inspiremd inc nspr  product pipeline analysis  update jun    globaldata   pages  usd  click here to open the popup youve added the following report to your cartclose cart summary total items subtotal      report summary table of contents companies request details related inspiremd inc inspiremd formerly saguaro resources inc is a medical device company that offers technology products the company develops and commercializes stent platform mguard technology its mguard is based on net that is wrapped with an expandable micronet inspiremd uses mguard technology develops products that are applied in interventional cardiology and other vascular procedures the company offers mguard prime which include mesh sleeve wrapped around a cobaltchromium stent it utilizes its technology to make products and offers solutions for various disease conditions such as stenting embolic showers restenosis and late stent thrombosis the company sells its products through a network of distributors in israel and germany inspiremd is headquartered in boston massachusetts the usthis report is a source for data analysis and actionable intelligence on the companys portfolio of pipeline products the report provides key information about the company its major products and brandsthe report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantagescopethe report reviews detailed company profile with information on business description key company facts major products and services key competitors key employees locations and subsidiaries and recent developmentsthe report analyzes all pipeline products in development for the company inspiremd incthe report provides pipeline analysis on all pipeline products of the company by equipment type by indication by development stage and by trial statusthe report covers detailed information on each pipeline product with information on pipeline territory stage of development device class regulatory path indications applications and estimated launch datethe report provides detailed description of products in development technical specification and functionsthe report also covers ongoing clinical trials wherever applicable with information on trial name trial objective sponsor trial design  trial status and phase estimated start and end datereasons to buydevelop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscapedesign and develop your product development marketing and sales strategies by understanding the competitor portfolioto formulate effective research  development strategiesdevelop marketentry and market expansion strategiesexploit inlicensing and outlicensing opportunities by identifying products most likely to ensure a robust returnplan mergers and acquisitions effectively by identifying key players of the most promising pipelineidentify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantagedevelop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials stage and of development etcidentify understand and capitalize the next highvalue products that your competitor would add in its portfolio table of contentstable of contents list of tables list of figures inspiremd inc company snapshot inspiremd inc company overview inspiremd inc pipeline products and clinical trials overview inspiremd inc  pipeline analysis overview key facts inspiremd inc  major products and services inspiremd inc pipeline products by development stage inspiremd inc clinical trials by trial status inspiremd inc pipeline products overview cguard embolic protection system cguard embolic protection system product overview cguard embolic protection system clinical trial mguard drug eluting stent mguard drug eluting stent product overview mguard embolic protection stent mguard embolic protection stent product overview mguard prime eps mguard prime eps product overview nvguard neurovascular nvguard neurovascular product overview pvguard peripheral pvguard peripheral product overview rguard renal rguard renal product overview inspiremd inc  key competitors inspiremd inc  key employees inspiremd inc  locations and subsidiaries head office other locations  subsidiaries recent developments inspiremd inc recent developments may   inspiremd reports financial results for the first quarter ended march   may   inspiremd announces latebreaking trial presentation on cguard embolic prevention system at europcr  conference mar   inspiremd reports financial results for the fourth quarter and year ended december   jan   inspiremd aligns operations and leadership team appoints isaac blech as vice chairman of the board dec   inspiremd receives eu regulatory approval for additional supplier of cguard delivery catheters nov   inspiremd announces positive twelve month followup carenet trial data at veith symposium  nov   inspiremd reports financial results for the third quarter ended september   oct   inspiremd announces cguard approval in argentina oct   inspiremd announces cguard approval in columbia sep   inspiremd announces full market launch of cguard distributed by penumbra at cirse annual congress appendix methodology about globaldata contact us disclaimer list of tablesinspiremd inc pipeline products and clinical trials overview inspiremd inc pipeline products by equipment type inspiremd inc pipeline products by indication inspiremd inc clinical trials by trial status inspiremd inc key facts inspiremd inc major products and services inspiremd inc number of pipeline products by development stage inspiremd inc pipeline products summary by development stage inspiremd inc clinical trials by trial status inspiremd inc clinical trials summary cguard embolic protection system  product status cguard embolic protection system  product description cguard embolic protection system  prospective evaluation of allcomer percutaneous carotid revascularization in symptomatic and increasedrisk asymptomatic carotid artery stenosis mguard drug eluting stent  product status mguard drug eluting stent  product description mguard embolic protection stent  product status mguard embolic protection stent  product description mguard prime eps  product status mguard prime eps  product description nvguard neurovascular  product status nvguard neurovascular  product description pvguard peripheral  product status pvguard peripheral  product description rguard renal  product status rguard renal  product description inspiremd inc key employees inspiremd inc other locations list of figuresinspiremd inc pipeline products by equipment type inspiremd inc pipeline products by development stage inspiremd inc clinical trials by trial status  companies mentioned in this reportinspiremd inc nspr this report does not have a press release associated with it order today format pdf  usd license single user delivery by email   business day the fast market research advantage only the best all of our research is sourced from the most trusted and established global analysts and consultancies client focused from startups to multinationals we focus on providing the right research to our diverse client base shop securely our usbased customer service team and ecommerce systems adhere to the highest data security standards industryleading customer support individualized assistance from our expert staff is never more than an email or phone call away best price guarantee we are committed to providing the best research at the lowest cost we will match any published price for the same report guaranteed easy ordering once you’ve found the right report click ‘order now’ and complete the checkout process using any major credit card check or wirebank transferneed multiuser or enterprise license pricing contact us for a custom quote about the publisher globaldata is a leading provider of global business intelligence including market competitor product and customer information it provides indepth research analysis data and forecasts through a range of interactive online databases reports and management briefings globaldata has a large team of experienced research and analysis consulting and marketing experts it has a global presence including key offices in the us europe and asia the group has over  years of experience of delivering market intelligence data and analysis and a highly experienced senior management team publisher details privacy policy  terms of use  flashalerts copyright copy  fast market research inc